Skip to main content
logo
Yarrow Bioscience, Inc. (YARW)
NASDAQ: YARW · Real-Time Price · USD
30.21
+1.36 (4.71%)
At close: Sep 4, 2026, 4:00 PM EDT
28.80
-1.41 (-4.67%)
After-hours: Sep 4, 2026, 7:30 PM EDT

Yarrow Bioscience Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025
Period Ending
Dec '25
Selling, General & Admin
1.56
Research & Development
2.42
Operating Expenses
3.98
Operating Income
-3.98
EBT Excluding Unusual Items
-3.98
Pretax Income
-283.98
Net Income
-283.98
Net Income to Common
-283.98
Net Income Growth
-
Shares Outstanding (Basic)
4
Shares Outstanding (Diluted)
4
Shares Change
-
EPS (Basic)
-66.82
EPS (Diluted)
-66.82
EPS Growth
-

Additional Metrics

Fiscal Year
FY 2025
Period Ending
Dec '25
EBIT
-3.98
SEC Filings: 10-K · 10-Q